A2PG, founded in 2007, is a leader in the fields of pharmacometrics and Model-Informed Drug Development (MIDD). A2PG's specialties include data management, population pharmacokinetic and exposure-response modeling, pediatric modeling and simulation, clinical trial simulation, and strategic consulting. A2PG scientists follow a team science approach, serving as integrated members of each client's team to implement model-based strategies and to support critical decision making. Over the past 15 years, A2PG has successfully supported over 200 BLA and NDA submissions in US and EU.